486 related articles for article (PubMed ID: 24569813)
1. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
2. SUMO proteomics to decipher the SUMO-modified proteome regulated by various diseases.
Yang W; Paschen W
Proteomics; 2015 Mar; 15(5-6):1181-91. PubMed ID: 25236368
[TBL] [Abstract][Full Text] [Related]
3. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
4. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
5. Neuron-specific SUMO knockdown suppresses global gene expression response and worsens functional outcome after transient forebrain ischemia in mice.
Zhang L; Liu X; Sheng H; Liu S; Li Y; Zhao JQ; Warner DS; Paschen W; Yang W
Neuroscience; 2017 Feb; 343():190-212. PubMed ID: 27919694
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation participates in induction of ischemic tolerance in mice.
Zhang H; Huang D; Zhou J; Yue Y; Wang X
Brain Res Bull; 2019 Apr; 147():159-164. PubMed ID: 30807794
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation pathway in Trypanosoma cruzi: functional characterization and proteomic analysis of target proteins.
Bayona JC; Nakayasu ES; Laverrière M; Aguilar C; Sobreira TJ; Choi H; Nesvizhskii AI; Almeida IC; Cazzulo JJ; Alvarez VE
Mol Cell Proteomics; 2011 Dec; 10(12):M110.007369. PubMed ID: 21832256
[TBL] [Abstract][Full Text] [Related]
8. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.
Liu YY; Kogai T; Schultz JJ; Mody K; Brent GA
J Biol Chem; 2012 Oct; 287(43):36499-508. PubMed ID: 22930759
[TBL] [Abstract][Full Text] [Related]
10. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers.
Rosas-Acosta G; Russell WK; Deyrieux A; Russell DH; Wilson VG
Mol Cell Proteomics; 2005 Jan; 4(1):56-72. PubMed ID: 15576338
[TBL] [Abstract][Full Text] [Related]
11. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation--a new target for therapeutic intervention?
Yang W; Sheng H; Homi HM; Warner DS; Paschen W
J Neurochem; 2008 Aug; 106(3):989-99. PubMed ID: 18410505
[TBL] [Abstract][Full Text] [Related]
12. Profiling the Murine SUMO Proteome in Response to Cardiac Ischemia and Reperfusion Injury.
Hotz PW; Wiesnet M; Tascher G; Braun T; Müller S; Mendler L
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260959
[TBL] [Abstract][Full Text] [Related]
13. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
14. Site-specific characterization of endogenous SUMOylation across species and organs.
Hendriks IA; Lyon D; Su D; Skotte NH; Daniel JA; Jensen LJ; Nielsen ML
Nat Commun; 2018 Jun; 9(1):2456. PubMed ID: 29942033
[TBL] [Abstract][Full Text] [Related]
15. SUMO2/3 conjugation is an endogenous neuroprotective mechanism.
Datwyler AL; Lättig-Tünnemann G; Yang W; Paschen W; Lee SL; Dirnagl U; Endres M; Harms C
J Cereb Blood Flow Metab; 2011 Nov; 31(11):2152-9. PubMed ID: 21863037
[TBL] [Abstract][Full Text] [Related]
16. SUMO and ischemic tolerance.
Lee YJ; Hallenbeck JM
Neuromolecular Med; 2013 Dec; 15(4):771-81. PubMed ID: 23775726
[TBL] [Abstract][Full Text] [Related]
17. Transient global cerebral ischemia induces a massive increase in protein sumoylation.
Yang W; Sheng H; Warner DS; Paschen W
J Cereb Blood Flow Metab; 2008 Feb; 28(2):269-79. PubMed ID: 17565359
[TBL] [Abstract][Full Text] [Related]
18. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model.
McMillan LE; Brown JT; Henley JM; Cimarosti H
Neurosci Lett; 2011 Sep; 502(3):201-8. PubMed ID: 21843595
[TBL] [Abstract][Full Text] [Related]
19. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.
Wang W; Matunis MJ
Cells; 2023 Dec; 13(1):. PubMed ID: 38201212
[TBL] [Abstract][Full Text] [Related]
20. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics.
Yang W; Thompson JW; Wang Z; Wang L; Sheng H; Foster MW; Moseley MA; Paschen W
J Proteome Res; 2012 Feb; 11(2):1108-17. PubMed ID: 22082260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
